Literature DB >> 12011451

Positive selection of self-MHC-reactive T cells by individual peptide-MHC class II complexes.

Gregory M Barton1, Courtney Beers, Paul deRoos, Susan R Eastman, Marcela E Gomez, Katherine A Forbush, Alexander Y Rudensky.   

Abstract

If T cells require specific interactions with MHC-bound peptides during positive selection, then the specificities of T cells selected by one peptide should be distinct from those selected by another. We have examined positive selection of CD4 T cells in four strains of mice, each overexpressing a different peptide-1-A(b)(A(b)) complex. We show that a subset of CD4 T cells is selected by the overexpressed peptide and that the specificities of the CD4 T cells, as measured by reactivity to wild-type antigen-presenting cells, vary greatly depending on which peptide is overexpressed. These differences in specificity are mediated through positive selection not negative selection. Each of the four peptide-A(b) complexes appears to adopt a different conformation, and these differences correlate with the differences in reactivity. Our results suggest that individual peptide-MHC complexes positively select different subsets of self-MHC-reactive T cells and that the conformation of the peptide-MHC complex may contribute to this process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12011451      PMCID: PMC124507          DOI: 10.1073/pnas.102645699

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Functionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-2M complexes.

Authors:  S Tourne; T Miyazaki; P Wolf; H Ploegh; C Benoist; D Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

2.  Selection of a broad repertoire of CD4+ T cells in H-2Ma0/0 mice.

Authors:  S Tourne; T Miyazaki; A Oxenius; L Klein; T Fehr; B Kyewski; C Benoist; D Mathis
Journal:  Immunity       Date:  1997-08       Impact factor: 31.745

3.  Deficient positive selection of CD4 T cells in mice displaying altered repertoires of MHC class II-bound self-peptides.

Authors:  C E Grubin; S Kovats; P deRoos; A Y Rudensky
Journal:  Immunity       Date:  1997-08       Impact factor: 31.745

Review 4.  In thymic selection, peptide diversity gives and takes away.

Authors:  M J Bevan
Journal:  Immunity       Date:  1997-08       Impact factor: 31.745

5.  Positive and negative CD4+ thymocyte selection by a single MHC class II/peptide ligand affected by its expression level in the thymus.

Authors:  Y Fukui; T Ishimoto; M Utsuyama; T Gyotoku; T Koga; K Nakao; K Hirokawa; M Katsuki; T Sasazuki
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

6.  H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection.

Authors:  W D Martin; G G Hicks; S K Mendiratta; H I Leva; H E Ruley; L Van Kaer
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

7.  Thymic selection by a single MHC/peptide ligand produces a semidiverse repertoire of CD4+ T cells.

Authors:  C D Surh; D S Lee; W P Fung-Leung; L Karlsson; J Sprent
Journal:  Immunity       Date:  1997-08       Impact factor: 31.745

8.  The imprint of intrathymic self-peptides on the mature T cell receptor repertoire.

Authors:  D B Sant'Angelo; P G Waterbury; B E Cohen; W D Martin; L Van Kaer; A C Hayday; C A Janeway
Journal:  Immunity       Date:  1997-10       Impact factor: 31.745

9.  Antigen presentation and T cell development in H2-M-deficient mice.

Authors:  W P Fung-Leung; C D Surh; M Liljedahl; J Pang; D Leturcq; P A Peterson; S R Webb; L Karlsson
Journal:  Science       Date:  1996-03-01       Impact factor: 47.728

10.  Invariant chain-independent function of H-2M in the formation of endogenous peptide-major histocompatibility complex class II complexes in vivo.

Authors:  S Kovats; C E Grubin; S Eastman; P deRoos; A Dongre; L Van Kaer; A Y Rudensky
Journal:  J Exp Med       Date:  1998-01-19       Impact factor: 14.307

View more
  5 in total

1.  Novel antigen-presenting cell imparts Treg-dependent tolerance to gut microbiota.

Authors:  Blossom Akagbosu; Zakieh Tayyebi; Gayathri Shibu; Yoselin A Paucar Iza; Deeksha Deep; Yollanda Franco Parisotto; Logan Fisher; H Amalia Pasolli; Valentin Thevin; Rasa Elmentaite; Maximilian Knott; Saskia Hemmers; Lorenz Jahn; Christin Friedrich; Jacob Verter; Zhong-Min Wang; Marcel van den Brink; Georg Gasteiger; Thomas G P Grünewald; Julien C Marie; Christina Leslie; Alexander Y Rudensky; Chrysothemis C Brown
Journal:  Nature       Date:  2022-09-07       Impact factor: 69.504

2.  A single peptide-MHC complex positively selects a diverse and specific CD8 T cell repertoire.

Authors:  Baomei Wang; Tina M Primeau; Nancy Myers; Henry W Rohrs; Michael L Gross; Lonnie Lybarger; Ted H Hansen; Janet M Connolly
Journal:  Science       Date:  2009-11-06       Impact factor: 47.728

3.  The somatically generated portion of T cell receptor CDR3α contributes to the MHC allele specificity of the T cell receptor.

Authors:  Philippa Marrack; Sai Harsha Krovi; Daniel Silberman; Janice White; Eleanor Kushnir; Maki Nakayama; James Crooks; Thomas Danhorn; Sonia Leach; Randy Anselment; James Scott-Browne; Laurent Gapin; John Kappler
Journal:  Elife       Date:  2017-11-17       Impact factor: 8.140

4.  Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response.

Authors:  Gabrielle A Rizzuto; Taha Merghoub; Daniel Hirschhorn-Cymerman; Cailian Liu; Alexander M Lesokhin; Diana Sahawneh; Hong Zhong; Katherine S Panageas; Miguel-Angel Perales; Grégoire Altan-Bonnet; Jedd D Wolchok; Alan N Houghton
Journal:  J Exp Med       Date:  2009-03-30       Impact factor: 14.307

5.  T cell immunodominance is dictated by the positively selecting self-peptide.

Authors:  Wan-Lin Lo; Benjamin D Solomon; David L Donermeyer; Chyi-Song Hsieh; Paul M Allen
Journal:  Elife       Date:  2014-01-14       Impact factor: 8.140

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.